Paraproteinemia, plasmacytoma, myeloma and HIV infection

被引:44
作者
Fiorino, AS
Atac, B
机构
[1] Albert Einstein Coll Med, Med Scientist Training Program, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA
[3] Jacobi Med Ctr, Dept Med, Bronx, NY USA
关键词
HIV; paraproteins; plasmacytoma; multiple myeloma;
D O I
10.1038/sj.leu.2400875
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have identified by MEDLINE search the cases of gammaglo-binopathy and plasma cell malignancy in HIV-positive patients reported in the English language literature, The average age at presentation among HIV-positive patients with plasma cell disorders is 33 years, far younger than the average age of presentation in the general population. Some of these patients present with transient paraproteinemias, while others have persistent paraproteins, which may or may not be associated with true plasma cell malignancies. In most cases in which it has been examined, the paraprotein contains high-titer anti-HIV activity. The presence of high titer anti HIV activity in the paraproteins of AIDS patients suggests that an antigen-driven process in response to HIV infection may contribute to the early development of plasma cell disorders in these patients. Recent work In plasma cell tumorigenesis has indicated that transformation at a single point in the B lymphocyte lineage can give rise to either lymphoma or myeloma, dependent upon environmental factors such as T cell function, which may be required for directing transformed lymphocytes from lymphoma and towards plasma cell differentiation. This may explain why B lineage oncogenesis in AIDS patients favors the development of lymphoma over that of myeloma.
引用
收藏
页码:2150 / 2156
页数:7
相关论文
共 90 条
[1]   THE CLONOGENIC PRECURSOR CELL IN MULTIPLE-MYELOMA [J].
BAKKUS, MHC ;
VANRIET, I ;
DEGREEF, C ;
VANCAMP, B ;
THIELEMANS, K .
LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) :221-229
[2]   EVIDENCE THAT THE CLONOGENIC CELL IN MULTIPLE-MYELOMA ORIGINATES FROM A PRE-SWITCHED BUT SOMATICALLY MUTATED B-CELL [J].
BAKKUS, MHC ;
VANRIET, I ;
VANCAMP, B ;
THIELEMANS, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (01) :68-74
[3]  
BERENSON J, 1987, BLOOD, V70, P1550
[4]  
Berenson J R, 1995, Curr Top Microbiol Immunol, V194, P25
[5]  
Bergsagel P L, 1995, Curr Top Microbiol Immunol, V194, P17
[6]   IN MULTIPLE-MYELOMA, CLONOTYPIC B-LYMPHOCYTES ARE DETECTABLE AMONG CD19(+) PERIPHERAL-BLOOD CELLS EXPRESSING CD38, CD56, AND MONOTYPIC IG LIGHT-CHAIN [J].
BERGSAGEL, PL ;
SMITH, AM ;
SZCZEPEK, A ;
MANT, MJ ;
BELCH, AR ;
PILARSKI, LM .
BLOOD, 1995, 85 (02) :436-447
[7]   IMMUNOGLOBULIN GENE SEQUENCE-ANALYSIS TO FURTHER ASSESS B-CELL ORIGIN OF MULTIPLE-MYELOMA [J].
BIGGS, DD ;
KRAJ, P ;
GOLDMAN, J ;
JEFFERIES, L ;
CARCHIDI, C ;
ANDERSON, K ;
SILBERSTEIN, LE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (01) :44-52
[8]  
Billadeau D, 1995, Curr Top Microbiol Immunol, V194, P9
[9]  
BILLADEAU D, 1992, BLOOD, V80, P1818
[10]   THE BONE-MARROW OF MULTIPLE-MYELOMA PATIENTS CONTAINS B-CELL POPULATIONS AT DIFFERENT STAGES OF DIFFERENTIATION THAT ARE CLONALLY RELATED TO THE MALIGNANT PLASMA-CELL [J].
BILLADEAU, D ;
AHMANN, G ;
GREIPP, P ;
VANNESS, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1023-1031